Reuters logo
4 个月前
BRIEF-Fortress Biotech reports orphan drug designations for cael-101 in amyloidosis
2017年4月5日 / 中午12点19分 / 4 个月前

BRIEF-Fortress Biotech reports orphan drug designations for cael-101 in amyloidosis

1 分钟阅读

April 5 (Reuters) - Fortress Biotech Inc:

* Fortress biotech announces orphan drug designations for cael-101 in amyloidosis Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below